KRX Growth Leaders With High Insider Ownership And At Least 21% Revenue Increase

The South Korean stock market has shown resilience, with the KOSPI recently edging higher amidst a mix of performances in global markets. This stability, coupled with anticipation surrounding upcoming economic data and policy announcements, sets a cautiously optimistic backdrop for investors. In such an environment, companies demonstrating robust revenue growth and significant insider ownership can be particularly compelling. These attributes often signal strong confidence in the company's prospects from those who know it best—its leaders.

Top 10 Growth Companies With High Insider Ownership In South Korea

Name	Insider Ownership	Earnings Growth
ALTEOGEN (KOSDAQ:A196170)	26.6%	73.1%
Global Tax Free (KOSDAQ:A204620)	18.1%	72.4%
S&S Tech (KOSDAQ:A101490)	21.6%	44.1%
Fine M-TecLTD (KOSDAQ:A441270)	17.3%	36.4%
Park Systems (KOSDAQ:A140860)	33.1%	35.8%
Seojin SystemLtd (KOSDAQ:A178320)	26.4%	48.1%
UTI (KOSDAQ:A179900)	34.1%	122.7%
HANA Micron (KOSDAQ:A067310)	19.8%	76.8%
INTEKPLUS (KOSDAQ:A064290)	16.3%	77.4%
Techwing (KOSDAQ:A089030)	18.7%	118.2%

Click here to see the full list of 82 stocks from our Fast Growing KRX Companies With High Insider Ownership screener.

We're going to check out a few of the best picks from our screener tool.

VM (KOSDAQ:A089970)

Simply Wall St Growth Rating: ★★★★★☆

Overview: VM Inc., headquartered in South Korea, specializes in manufacturing and selling dry etcher systems for the semiconductor production process, with a market capitalization of approximately ₩389.27 billion.

Operations: The firm specializes in the production and global distribution of dry etcher systems for semiconductor manufacturing.

Insider Ownership: 29.4%

Revenue Growth Forecast: 61.9% p.a.

VM Inc., a South Korean company, is poised for significant growth with its revenue expected to increase by 61.9% annually, outpacing the local market's average of 10.3%. Despite trading at 85.8% below its estimated fair value and having a volatile share price in recent months, VM's financial outlook remains robust with earnings projected to grow by 103.3% per year. However, shareholder equity has been diluted over the past year, and the forecasted Return on Equity is relatively low at 15.5%.

• Get an in-depth perspective on VM's performance by reading our analyst estimates report here.
• Our valuation report here indicates VM may be overvalued.

ALTEOGEN (KOSDAQ:A196170)

Simply Wall St Growth Rating: ★★★★★★

Overview: ALTEOGEN Inc. is a biopharmaceutical company engaged in developing long-acting biobetters, proprietary antibody-drug conjugates, and antibody biosimilars, with a market capitalization of approximately ₩15.06 billion.

Operations: The company specializes in the development of long-acting biobetters, proprietary antibody-drug conjugates, and biosimilars.

Insider Ownership: 26.6%

Revenue Growth Forecast: 48.3% p.a.

ALTEOGEN, a South Korean biotech firm, is experiencing robust growth with its revenue and earnings forecast to expand by 48.3% and 73.1% per year respectively, well above the local market averages. Despite this promising outlook, the company's share price has been highly volatile recently. Additionally, shareholder equity was diluted over the past year. ALTEOGEN's Return on Equity is expected to be very high at 45.2% in three years, underscoring strong profitability potential despite current challenges.

• Click to explore a detailed breakdown of our findings in ALTEOGEN's earnings growth report.
• According our valuation report, there's an indication that ALTEOGEN's share price might be on the expensive side.

CLASSYS (KOSDAQ:A214150)

Simply Wall St Growth Rating: ★★★★★☆

Overview: CLASSYS Inc. operates globally, specializing in the provision of medical aesthetics devices, with a market capitalization of approximately ₩3.08 billion.

Operations: The company specializes in the global provision of medical aesthetics devices, generating approximately ₩3.08 billion in market capitalization.

Insider Ownership: 10.1%

Revenue Growth Forecast: 21.3% p.a.

CLASSYS, a South Korean company, is set to grow its earnings by 22.18% annually and its revenue by 21.3% per year, surpassing the local market's growth rate. Despite this positive outlook, its share price has been highly volatile over the past three months. The firm has maintained high insider ownership but lacks recent substantial insider trading activity. Recent engagements in multiple high-profile investment conferences underscore its active pursuit of visibility and investor confidence.

• Unlock comprehensive insights into our analysis of CLASSYS stock in this growth report.
• Our expertly prepared valuation report CLASSYS implies its share price may be too high.

Where To Now?

• Click here to access our complete index of 82 Fast Growing KRX Companies With High Insider Ownership.
• Shareholder in one or more of these companies? Ensure you're never caught off-guard by adding your portfolio in Simply Wall St for timely alerts on significant stock developments.
• Join a community of smart investors by using Simply Wall St. It's free and delivers expert-level analysis on worldwide markets.

Contemplating Other Strategies?

• Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
• Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence.
• Find companies with promising cash flow potential yet trading below their fair value.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com